[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "UK variant increases mortality", "description": "Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study\n\nhttps://www.bmj.com/content/372/bmj.n579\n\n54 906 matched pairs of participants\n\nTested positive, between 1 October 2020 and 29 January 2021\n\nFollowed-up until 12 February 2021\n\nDeath within 28 days of the first positive SARS-CoV-2 test result. \n\nMortality hazard ratio associated with infection with VOC-202012/1 compared with old variant, 1.64\n\nRepresents an increase in deaths from 2.5 to 4.1 per 1000 detected cases\n\nPhase 3, 15,000 (UK) 30,000 (US and Mexico)\n\nReporting in April\n\n2 doses\n\nIntramuscular\n\nEfficacy, 89.3% (UK data)\n\nMuch lower in SA\n\nDeveloping a new version to combat SA variant\n\nProtein based\n\nUS government support, $1.6 billion\n\nProducing 2 billion doses per year in India\n\nhttps://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html#novavax\n\nhttps://www.washingtonpost.com/health/2021/03/11/novavax-coronavirus-vaccine/\n\nhttps://www.novavax.com/covid-19-coronavirus-vaccine-candidate-updates\n\nEfficacy, original strain, 96%, against mild, moderate and severe disease\n\nEfficacy, B.1.1.7, 86%, against mild, moderate and severe disease\n\nEfficacy, B.1.351 55%, against mild, moderate and severe disease (in non-HIV)\n\n100% percent effective against severe disease, including against the variants\n\nAll severe cases were in the placebo groups in UK and SA\n\nGregory Glenn, Novavax\n\nOur take on this is this is a very good result. It is important to prevent severe disease; it would be ideal to prevent all disease\n\nUS\n\nMr. Biden\n\nAll adults to be eligible for vaccination by 1st May\n\nSmall scale 4th July 1776\n\nindependence from this virus\n\nA lot can happen. Conditions can change. The scientists have made clear that things may get worse again as new variants of the virus spread.\n\nhttps://www.washingtonpost.com/politics/biden-address-vaccine/2021/03/11/2cde7132-8278-11eb-9ca6-54e187ee4939_story.html\n\nFind a vaccination website \n\n(Web sites and phone lines a bottle neck?)\n\nDentists, veterinarians \n\nDouble the number of pharmacies participating\n\nDouble the number of federally run mass vaccination centers\n\nMaintaining the current pace of 2 million a day\n\nCurrently, 2,233,006 per day\n\nMr. Trump\n\nthat beautiful shot \n\nU.S. Olympic and Paralympic Committee\n\nChina\n\nOffers vaccines to all Olympic competitors\n\nJuly 23\n\nTokyo and Beijing Games\n\nSinovac and Sinopharm, pledged half-billion to 45 countries\n\nImmunizing people aged 18-59\n\nCanada\n\nHopes to have vaccinated adults by end of September\n\nKenya\n\nExtends nationwide Covid curfew for 60 days\n\nCases, 111,185\n\nDeaths, 1,899\n\nPositive test rate, 13%\n\nJanuary it was 2%\n\nItaly \n\nCases, + 25,673\n\nDeaths, + 373 = 101,184\n\nLocalised surges in new cases\n\nLombardy, Lazio, complete lockdown from Monday\n\nHigh-risk red-zones, if they have over 250 weekly cases per 100,000\n\nOxford AZ suspension\n\nItaly, Romania, Thailand\n\nDenmark, Norway and Iceland\n\nAustria, Estonia, Latvia, Lithuania, Luxemburg (specific batch)\n\nGermany\n\nhttps://www.dw.com/en/astrazeneca-vaccine-germany-rejects-blood-clot-risk/a-56849749\n\nHealth Minister Jens Spahn\n\nNo evidence of an increase in blood clots with AZ\n\nI regret that ... some countries in the European Union have suspended vaccination with AstraZeneca\n\nFrom what we know so far, the benefit ... is far greater than the risk\n\nFrance and UK\n\nEMA\n\nBlood clots, no higher than that seen in the general population\n\nIt is not yet clear whether there is a causal association between vaccination and the reports of immune thrombocytopenia\n\nhttps://www.theguardian.com/world/live/2021/mar/12/coronavirus-live-news-brazil-records-more-than-2000-deaths-for-second-day-eu-approves-jj-vaccine\n\nWorld Health Organization \n\nAstraZeneca, excellent vaccine, as are the other vaccines that are being used\n\nSafe\n\nWe've reviewed the data on deaths. There has been no death, to date, proven to have be caused by vaccination\n\nUK\n41 reports of possible anaphylaxis from 5 million AZ vaccinations\n\nGlobal vaccines\n\nhttps://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/#global", "link": "https://www.youtube.com/watch?v=w9OxwJMOagI", "date_published": "2021-03-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vaccine side effects", "description": "EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU\n\nhttps://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-janssen-authorisation-eu\n\nJanssen should start delivering vaccines by April, and significant amounts by May\n\nhttps://nos.nl/artikel/2372206-vierde-coronavaccin-goedgekeurd-voor-eu-janssen-krijgt-positief-oordeel.html\n\nRecommended conditional marketing authorisation, 18 years +\n\nConcluded by consensus that the data on the vaccine were robust and met the criteria for efficacy, safety and quality\n\n4th vaccine now for EU, first single dose\n\nPhase 3\n\nN = over 44,000\n\nRCT\n\nHalf and half\n\n67% reduction in the number of symptomatic cases after 2 weeks\n\nUS efficacy data\n\n72% effective in preventing moderate illness\n\n85% effective at protecting against severe cases \n\n100% effective in preventing hospitalization and death after one month\n\nSide effects\n\nUsually mild or moderate\n\nCleared within a couple of days\n\nPain at the injection site, headache, tiredness, muscle pain and nausea\n\nPharmacovigilance will continue\n\nUK\n\nOrdered 30 million J and J\n\nDenmark \n\n14 day halt in use of the Oxford-AstraZeneca vaccine\n\nBlood clots, and one death\n\nHealth Minister Magnus Heunicke\n\nprecautionary measure\n\nwe must respond in a timely and careful manner\n\nAustria\n\nOne woman (49) died 10 days after vaccination\n\nEstonia, Latvia, Lithuania, Luxemburg have also stopped using the batch\n\nEMA\n\nProbably 3 cases and one death\n\nOne million doses in batch\n\nSafety committee was reviewing the Austrian case\n\nthere is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine\n\nthromboembolic events in vaccinated people is no higher than that seen in the general population\n\n22 cases of thromboembolic events, three million people vaccinated with AstraZeneca vaccine in the European Economic Area\n\nAuthorised 29th January\n\nEpidemiology of venous thromboembolism\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624298/\n\nIncidence rate\n\nMen, 130 per 100,000 per year\n\nWomen, 110 per 100,000 per year\n\nThat\u2019s 10 per month per 100,000\n\nThat\u2019s 120 per million per month\n\nTherefore for 3 million of the population 360 thromboembolic events expected per month\n\nCzech Republic\n\nSent first patients to Poland\n\nHungary\n\nCases higher than in December\n\nPoland\n\nCases highest since late November\n\nincreased looseness among Poles towards anti-Covid measures\n\nBrazil\n\nPopulation 214 million\n\nhttps://www.bbc.co.uk/news/world-latin-america-56355861\n\nCases, 79,876\n\nDeaths, + 2,000 = 270,656\n\nSecond highest death numbers\n\nMargareth Dalcolmo, doctor and researcher at Fiocruz\n\nthe worst moment of the pandemic in Brazil\n\noverload and even collapse of health systems\n\nDr Pedro Hallal, Epidemiologist\n\nIf we do not start vaccinating the population here very soon, it will become a massive tragedy\n\nIt took a long time for the politicians to act\n\nP.1\n\nCould be up to twice as transmittable as the original virus\n\nChance of reinfection, 25% to 60%\n\nBrazil, natural laboratory, when coronavirus goes relatively unchecked\n\nBreeding ground for new variants, several VOCs circulating\n\nRapid vaccination and NPIs required\n\nVaccines remains efficacious, but probably slight reductions", "link": "https://www.youtube.com/watch?v=7rMvPe_FsDg", "date_published": "2021-03-11 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]